Raymond James & Associates Amneal Pharmaceuticals, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 161,380 shares of AMRX stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161,380

Previous 162,125 0.46%

Holding current value

$1.88 Million

Previous $1.03 Million 30.42%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$6.42 - $8.83 $4,782 - $6,578	-745 Reduced 0.46%	161,380 $1.34 Million
Q2 2024 Jul 19, 2024	SELL	$5.36 - $7.11 $15,881 - $21,066	-2,963 Reduced 1.79%	162,125 $1.03 Million
Q1 2024 Apr 22, 2024	BUY	$5.24 - $6.34 $18,083 - $21,879	3,451 Added 2.14%	165,088 $1 Million
Q4 2023 Jan 16, 2024	SELL	$3.36 - $6.21 $66,360 - $122,647	-19,750 Reduced 10.89%	161,637 $981,000
Q3 2023 Oct 24, 2023	BUY	$2.76 - $4.59 $55,199 - $91,800	20,000 Added 12.39%	181,387 $765,000

Q3 2022 Oct 25, 2022	SELL	$2.02 - $3.62 $9,263 - $16,601	-4,586 Reduced 2.76%	161,387 $326,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $4.46 $6,020 - $8,920	-2,000 Reduced 1.19%	165,973 $528,000
Q1 2022 May 11, 2022	SELL	$3.9 - $4.89 $17,550 - $22,005	-4,500 Reduced 2.61%	167,973 $700,000
Q4 2021 Feb 08, 2022	SELL	$3.95 - $5.85 $10,187 - $15,087	-2,579 Reduced 1.47%	172,473 $826,000
Q3 2021 Nov 02, 2021	BUY	$4.31 - $5.64 $8,620 - $11,280	2,000 Added 1.16%	175,052 $935,000
Q2 2021 Aug 11, 2021	BUY	$5.12 - $6.82 $15,360 - $20,460	3,000 Added 1.76%	173,052 $886,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $18,803 - $29,276	-3,967 Reduced 2.28%	170,052 $1.14 Million
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $829 - $1,138	-210 Reduced 0.12%	174,019 $795,000
Q3 2020 Nov 04, 2020	BUY	$3.54 - $5.27 $22,886 - $34,070	6,465 Added 3.85%	174,229 $676,000
Q2 2020 Jul 28, 2020	BUY	$2.87 - $5.46 $717 - $1,365	250 Added 0.15%	167,764 $799,000
Q1 2020 Apr 21, 2020	BUY	$2.46 - $5.35 $91,020 - $197,950	37,000 Added 28.35%	167,514 $583,000
Q4 2019 Feb 12, 2020	BUY	$2.65 - $5.56 $87,132 - $182,812	32,880 Added 33.68%	130,514 $629,000
Q3 2019 Nov 07, 2019	BUY	$2.29 - $7.1 $123,524 - $382,981	53,941 Added 123.45%	97,634 $283,000
Q2 2019 Aug 06, 2019	BUY	$6.44 - $14.29 $37,345 - $82,867	5,799 Added 15.3%	43,693 $313,000
Q1 2019 May 06, 2019	SELL	$11.87 - $14.84 $107,316 - $134,168	-9,041 Reduced 19.26%	37,894 $537,000
Q4 2018 Feb 11, 2019	SELL	$13.09 - $21.49 $155,247 - $254,871	-11,860 Reduced 20.17%	46,935 $635,000
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $243,277 - $360,021	14,834 Added 33.74%	58,795 $1.31 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $613,255 - $888,012	43,961 New	43,961 $721,000

Others Institutions Holding AMRX

# of Institutions

257

Shares Held

150M

Call Options Held

357K

Put Options Held

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Amneal Pharmaceuticals, Inc. Transaction History